Clinical reminders for hepatocellular carcinoma surveillance: An early step in a long journey

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 1, 2015, Pages 180-182

  Tian, Chenlu ^a   Singal, Amit G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; EDITORIAL; FOLLOW UP; GASTROENTEROLOGIST; HEPATITIS B; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MASS SCREENING; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TERTIARY CARE CENTER; THROMBOCYTE COUNT; CARCINOMA, HEPATOCELLULAR; COMPLICATION; FEMALE; MALE; PRIMARY HEALTH CARE; PROCEDURES; REMINDER SYSTEM;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PRIMARY HEALTH CARE; REMINDER SYSTEMS;

EID: 84917676565     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.07.033     Document Type: Editorial

References (27)

1. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999, 29:62-67.
2. Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. JCancer Res Clin Oncol 2004, 130:417-422.
3. Singal A.G., Conjeevaram H.S., Volk M.L., et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012, 21:793-799.
4. Singal A.G., Nehra M., Adams-Huet B., et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?. Am J Gastroenterol 2013, 108:425-432.
5. Singal A.G., Pillai A., Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014, 11:e1001624.
6. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010, 53:1-35.
7. Kanwal F., Kramer J., Asch S.M., et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol 2010, 8:709-717.
8. Davila J.A., Morgan R.O., Richardson P.A., et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010, 52:132-141.
9. Singal A.G., Yopp A., Skinner S.C., et al. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. JGen Intern Med 2012, 27:861-867.
10. Zapka J.G., Taplin S.H., Solberg L.I., et al. Aframework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev 2003, 12:4-13.
11. Singal A.G., Yopp A.C., Gupta S., et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012, 5:1124-1130.
12. Singal A., Volk M., Rakoski M., et al. Patient involvement is correlated with higher HCC surveillance in patients with cirrhosis. JClin Gastroenterol 2011, 45:727-732.
13. Beste L.A., Ioannou G.N., Yang Y., et al. Improved surveillance for hepatocellular carcinoma with a primary care-oriented clinical reminder. Clin Gastroenterol Hepatol 2015, 13:172-179.
14. Wigg A.J., McCormick R., Wundke R., et al. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol 2013, 11:850-858. e1-4.
15. Aberra F.B., Essenmacher M., Fisher N., et al. Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci 2013, 58:1157-1160.
16. Dalton-Fitzgerald E., Tiro J., Kandunoori P., et al. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014 Jul 11, Epub ahead of print.
17. Shojania K.G., Jennings A., Mayhew A., et al. Effect of point-of-care computer reminders on physician behaviour: a systematic review. CMAJ 2010, 182:E216-E225.
18. Kanwal F. Coordinating care in patients with cirrhosis. Clin Gastroenterol Hepatol 2013, 11:859-861.
19. Volk M.L., Piette J.D., Singal A.S., et al. Chronic disease management for patients with cirrhosis. Gastroenterology 2010, 139:14-16.e1.
20. Singal A., Volk M.L., Waljee A., et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009, 30:37-47.
21. Trevisani F., De Notariis S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002, 97:734-744.
22. Mourad A., Deuffic-Burban S., Ganne-Carrie N., et al. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology 2014, 59:1471-1481.
23. Stravitz R.T., Heuman D.M., Chand N., et al. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med 2008, 121:119-126.
24. El-Serag H.B., Kanwal F., Davila J.A., et al. Anew laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology 2014, 146:1249-1255.e1.
25. Gopal P., Yopp A.C., Waljee A.K., et al. Factors that affect accuracy of alpha-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014, 12:870-877.
26. Lee E., Edward S., Singal A.G., et al. Improving screening for hepatocellular carcinoma by incorporating data on levels of alpha-fetoprotein, over time. Clin Gastroenterol Hepatol 2013, 11:437-440.
27. Singal A.G., Tiro J.A., Gupta S. Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol 2013, 11:472-477.